GlassScriptPhysician profile
Ryan Huang
NPI 1871942151
$17,579.11
in general payments reported to CMS, 2019-2025
64 companies · $3,006 in 2025
The $3,006 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,341 · 2020: $1,097 · 2021: $3,316 · 2022: $3,476 · 2023: $2,354 · 2024: $1,989 · 2025: $3,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,248 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,248.06 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $2,012.09 | 2019-2023 | V.A.C. Veraflo |
| Astrazeneca Pharmaceuticals LP | $1,596.83 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,541.78 | 2019-2025 | Ozempic, Rybelsus |
| Biohaven Pharmaceuticals, INC. | $1,242.45 | 2021 | |
| Scynexis, INC. | $1,149.48 | 2022 | |
| Gilead Sciences, INC. | $1,119.63 | 2019-2025 | Vemlidy |
| Kerecis Limited | $1,000.18 | 2021-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Amgen INC. | $731.24 | 2019-2025 | Otezla, Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $668.77 | 2022-2025 | |
| Smith+Nephew, INC. | $488.98 | 2019-2025 | Collagenase Santyl, Renasys Touch, Grafix |
| Dexcom, INC. | $476.70 | 2019-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $420.39 | 2021-2025 | |
| Mannkind Corporation | $414.64 | 2019-2025 | Afrezza |
| Redhill Biopharma INC. | $388.07 | 2020-2023 | Talicia, Aemcolo, Movantik |
| Mimedx Group, INC. | $365.31 | 2025 |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $319.49 | 2021-2025 | Nuzyra |
| Astellas Pharma US INC | $246.11 | 2021-2023 | Myrbetriq, Veozah |
| Organogenesis INC. | $240.08 | 2019-2025 | Puraply Wound Matrix, Puraply Am |
| Radius Health, INC. | $208.28 | 2025 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $186.38 | 2021-2025 | Jardiance |
| Pfizer INC. | $185.89 | 2019-2025 | |
| Lifenet Health | $177.08 | 2025 | Theragenesis Wound Matrix |
| Esperion Therapeutics, INC. | $165.09 | 2021-2025 | Nexletol |
| Corium, LLC | $149.01 | 2023 | Adlarity |
| Glaxosmithkline, LLC. | $148.48 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Abbott Laboratories | $144.73 | 2019-2024 | Freestyle Libre 3, Proclaim |
| Hydrofera LLC | $135.15 | 2024 | Hydrofera Blue |
| Solventum Corporation | $130.90 | 2024-2025 | Activ.A.C. |
| Horizon Therapeutics Plc | $110.08 | 2022-2023 | Krystexxa |
| Sanofi-Aventis U.S. LLC | $107.23 | 2019-2025 | |
| Lilly USA, LLC | $105.72 | 2020-2025 | Jardiance, Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $100.12 | 2023-2025 | |
| Ironwood Pharmaceuticals, INC | $95.20 | 2023-2024 | Linzess |
| Amarin Pharma, INC. | $86.35 | 2021-2022 | |
| Advanced Respiratory, INC | $84.91 | 2020 | |
| Convatec INC. | $76.68 | 2022-2023 | |
| Ascensia Diabetes Care US INC. | $74.63 | 2025 | |
| Merck Sharp & Dohme LLC | $63.09 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $63.09 | 2024-2025 | Gemtesa |
| Janssen Pharmaceuticals, INC | $50.00 | 2019 | |
| Kyowa Kirin, INC. | $48.36 | 2025 | |
| Shield Therapeutics INC | $37.33 | 2022-2024 | |
| Idorsia Pharmaceuticals US INC | $33.86 | 2023 | Quviviq |
| Next Science LLC | $30.02 | 2023 | Xperience, Blastx, Surgx |
| Lundbeck LLC | $28.67 | 2024 | Vyepti |
| Clarus Therapeutics INC. | $24.64 | 2021 | |
| Melinta Therapeutics, LLC | $23.43 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.03 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $19.18 | 2025 | Zoryve |
| Boston Scientific Corporation | $19.17 | 2025 | General - Pain Management |
| Urgo Medical North America, LLC | $18.96 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Acera Surgical, INC. | $18.92 | 2022 | |
| Collegium Pharmaceutical, INC. | $18.00 | 2021 | |
| Phadia US INC. | $17.28 | 2025 | Immunocap |
| E.R. Squibb & Sons, L.L.C. | $17.01 | 2019 | |
| Medela LLC | $16.71 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.44 | 2022 | |
| Xeris Pharmaceuticals, INC. | $16.15 | 2025 | Gvoke Hypopen |
| Exact Sciences Corporation | $15.36 | 2024 | Cologuard Collection Kit |
| Advanced Oxygen Therapy INC. | $14.59 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.57 | 2025 | Caplyta |
| Hologic Sales and Service, LLC | $13.84 | 2021 | |
| Biocomposites INC | $13.15 | 2025 | Stimulan |
| Tactile Systems Technology INC | $13.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.